[Sample Collection] Detecting cancers Earlier Through Elective plasma-based Cancer SEEK Testing (DETECT-ASCEND 2)
Condition: Solid Tumors
Sponsor: Exact Sciences Thrive LLC
Protocol THR-CS-001: Detecting cancers Earlier Through Elective plasma-based CancerSEEK Testing – Ascertaining Serial Cancer patients to Enable New Diagnostic II (DETECT-ASCEND 2)
Observational, sample collection study for patients with a new, untreated diagnosis of one of the following malignancies:
Breast, lung, colorectal, bladder, uterine, kidney/renal pelvis, pancreatic, liver, stomach, ovarian, esophageal cancer, head and neck squamous cell, thyroid, small intestine, cervical, anal, vulva, or testis
For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.